Voyager Therapeutics Cash from Financing (TTM) Analysis

Voyager Therapeutics Inc (VYGR)

8.925 +0.12 (+1.31%) USD | NASDAQ | May 06, 16:00

8.925 0.00 (0.00%) After-Hours: 19:23

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	33.64M
September 30, 2023	33.46M
June 30, 2023	33.14M
March 31, 2023	32.40M
December 31, 2022	1.11M
September 30, 2022	1.061M
June 30, 2022	1.046M
March 31, 2022	0.596M
December 31, 2021	0.612M
September 30, 2021	0.871M
June 30, 2021	1.381M
March 31, 2021	3.157M
December 31, 2020	3.163M
September 30, 2020	2.977M
June 30, 2020	4.191M
March 31, 2020	3.127M
December 31, 2019	80.99M

Date	Value
September 30, 2019	81.13M
June 30, 2019	80.77M
March 31, 2019	80.82M
December 31, 2018	4.749M
September 30, 2018	62.58M
June 30, 2018	61.77M
March 31, 2018	61.15M
December 31, 2017	59.92M
September 30, 2017	2.024M
June 30, 2017	1.521M
March 31, 2017	1.112M
December 31, 2016	0.514M
September 30, 2016	74.06M
June 30, 2016	73.05M
March 31, 2016	132.81M
December 31, 2015	177.74M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.596M

Minimum

Mar 2022

81.13M

Maximum

Sep 2019

20.99M

Average

3.157M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks